RenalSense Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 18


  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $14M

  • Investors
  • 5

RenalSense General Information


Developer of a critical care monitoring system designed for real-time renal diagnostics, especially for patients at risk of acute kidney injury. The company's monitoring system continuously measures urine flow, automatically transmitting real-time data and notifications of fluctuations, on a clock basis, facilitating doctors with early detection of changes in renal function and acute kidney injury risk, enabling the medical system to access a suitable technology for early detection of changes and prevention of disease progression.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Diagnostic Equipment
Other Healthcare Technology Systems
Primary Office
  • Hamarpe 3, Har Hotzvim
  • POB 45397
  • Jerusalem 9145101
  • Israel
+972 00-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RenalSense Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series A) 22-Nov-2021 $14M 0000 Completed Generating Revenue
4. Grant 01-Nov-2019 000.00 000 Completed Generating Revenue
3. Grant 30-May-2019 00000 000 Completed Generating Revenue
2. Angel (individual) 01-Jan-2018 $3.5M $8M Completed Generating Revenue
1. Later Stage VC (Series A) 31-Dec-2015 $4.5M $4.5M Completed Generating Revenue
To view RenalSense’s complete valuation and funding history, request access »

RenalSense Patents

RenalSense Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3755975-A1 Sensor unit Pending 19-Feb-2018 000000000
US-11333534-B2 Sensor unit Active 19-Feb-2018 000000000 0
US-20200393273-A1 Sensor unit Active 19-Feb-2018 000000000
US-20220236087-A1 Sensor unit Pending 19-Feb-2018 000000000 0
EP-3755975-A4 Sensor unit Pending 19-Feb-2018 G01D11/30 0
To view RenalSense’s complete patent history, request access »

RenalSense Executive Team (6)

Name Title Board Seat Contact Info
Avi Kleiman Co-Founder, Chief Executive Officer & Chairman
Yohanan Engelhardt Chief Financial Officer
Moti Barda Chief Operating Officer
Adam Goldberger Chief Business Officer
Joseph Kochba Vice President, Research & Development
You’re viewing 5 of 6 executive team members. Get the full list »

RenalSense Board Members (4)

Name Representing Role Since
Avi Kleiman RenalSense Co-Founder, Chief Executive Officer & Chairman 000 0000
Cuong Do Self Board Member 000 0000
Milton Yisrael RenalSense Board Member 000 0000
Yishai Klein Self Board Member 000 0000
To view RenalSense’s complete board members history, request access »

RenalSense Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RenalSense Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BlueRed Partners Venture Capital Minority 000 0000 000000 0
Thylacine Capital Venture Capital Minority 000 0000 000000 0
Horizon 2020 SME Instrument Government 000 0000 000000 0
Israel Innovation Authority Government 000 0000 000000 0
Ministry of Economy and Industry Government 000 0000 000000 0
To view RenalSense’s complete investors history, request access »